Physician profile
Michael Robert Levitt
NPI 1497955595
$5,496.22
in general payments reported to CMS, 2019-2025
12 companies · $1,238 in 2025
The $1,238 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,168 · 2020: $1,381 · 2022: $532 · 2023: $178 · 2025: $1,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766 · Consulting Fee: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.66 |
| Consulting Fee | $650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,382.66 | 2019-2022 | |
| Medtronic USA, INC. | $1,440.72 | 2019-2020 | |
| Aidoc Medical Ltd | $650.00 | 2025 | Briefcase |
| Microvention, INC. | $354.40 | 2019-2025 | Bobby, Web Aneurysm Embolization System |
| Balt USA, LLC | $188.19 | 2025 | Optima Coil System |
| Medtronic, INC. | $177.88 | 2023 | Pipeline |
| Depuy Synthes Sales INC. | $131.35 | 2025 | |
| Irras USA, INC. | $107.82 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.42 | 2019 | |
| Route 92 Medical, INC. | $20.63 | 2025 | |
| Stryker Corporation | $18.15 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Levitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.